Market Place
Sourcing Support
Cellectar Bioscience, Nusano Sign Multi-Isotope Supply Deal
26 Jun 2025 //
GLOBENEWSWIRE
dGenThera & Nusano Sign Letter of Intent for Astatine?211 Supply
19 Jun 2025 //
GLOBENEWSWIRE
Ratio, Nusano Ink Multi-Isotope Pact For Cancer Drugs
17 Jun 2025 //
PR NEWSWIRE
Nusano`s HALEU Program to Produce 350 Metric Tons Annually
11 Jun 2025 //
GLOBENEWSWIRE
Nusano Program Enriches Gadolinium-160 to 99.2% Purity
10 Jun 2025 //
GLOBENEWSWIRE
Registration for 2025 World Astatine Community Meeting Now Open
12 May 2025 //
GLOBENEWSWIRE
Nusano Names Rachel Culbertson VP of Supply Chain
30 Apr 2025 //
GLOBENEWSWIRE
Clarity signs copper-64 Supply Agreement with Nusano
17 Apr 2025 //
PR NEWSWIRE
Nusano’s Jzaneen Lalani Named Top 50 Women In Health Tech
07 Mar 2025 //
GLOBENEWSWIRE
Nusano To Present At B. Riley Precision Oncology Conference
25 Feb 2025 //
GLOBENEWSWIRE
Nusano, Atomiq Collaborate on Nuclear Battery Tech
24 Feb 2025 //
GLOBENEWSWIRE
Nusano Wins "Researcher Of The Year" At Best Of BioHive Awards
21 Feb 2025 //
GLOBENEWSWIRE
Nusano to Present at Oppenheimer 35th Annual Healthcare Conference
07 Feb 2025 //
GLOBENEWSWIRE
Nusano And Caspian Launch “Talk Radioisotopes” Podcast
22 Jan 2025 //
GLOBENEWSWIRE
Nusano to Present at Piper Sandler Next-Gen RadioPharma Symposium
22 Jan 2025 //
GLOBENEWSWIRE
Nusano & Atley Collaborate To Accelerate Astatine-211 Development
16 Jan 2025 //
GLOBENEWSWIRE
Nusano Announces Isotope Availability
10 Jan 2025 //
GLOBENEWSWIRE
Nusano Hosts Virtual Panel On Radioligand Therapy (Dec 17, 2024)
11 Dec 2024 //
GLOBENEWSWIRE
Nusano and GlyTherix Announce Lutetium-177 Supply Agreement
09 Dec 2024 //
GLOBENEWSWIRE
Nusano Names Medical Radioisotopes Advisory Board
03 Dec 2024 //
GLOBENEWSWIRE
Nusano to Present at William Blair Virtual RadioPharma Event
12 Nov 2024 //
GLOBENEWSWIRE
Nusano And Starget Pharma Announce Radioligand Supply Agreement
17 Oct 2024 //
GLOBENEWSWIRE
Nusano Presenting at Industry Events in October
07 Oct 2024 //
GLOBENEWSWIRE
Nusano Expands Leadership Team Before 2025 Launch
03 Oct 2024 //
GLOBENEWSWIRE
Nusano Announces $115M Series C Financing for Radioisotopes
01 Oct 2024 //
GLOBENEWSWIRE
Nusano, PharmaLogic Enter Supply Agreement to Provide Critical Radioisotopes
10 Jul 2024 //
CONTRACT PHARMA
Nusano And PharmaLogic Form Strategic Radiopharmaceutical Supply Agreement
10 Jul 2024 //
PR NEWSWIRE
Nusano, PharmaLogic Ink Deal For Radiopharmaceutical Supplies
09 Jul 2024 //
PRESS RELEASE
Nusano To Host Virtual Event "Office Hours: Radiopharmaceuticals" On June 28
20 Jun 2024 //
GLOBENEWSWIRE
Nusano Names D. Scott Holbrook as Chairman of its Board
07 Jun 2024 //
GLOBENEWSWIRE
Nusano Expands Mgmt Ahead Of Q1 2025 Radioisotope Commercialization
29 May 2024 //
GLOBENEWSWIRE
Nusano to Present at Jefferies Radiopharma Innovation Summit
10 Apr 2024 //
GLOBENEWSWIRE
Nusano to Present Isotope Production Capabilities and Commercialization Plans
20 Mar 2024 //
GLOBENEWSWIRE
Nusano Opens Radiochemistry Laboratory
11 Mar 2024 //
GLOBENEWSWIRE
Nusano to Participate in the B. Riley Securities Radiopharma Investor Conference
26 Feb 2024 //
GLOBENEWSWIRE
Nusano Names Rohan Jain as Commercial General Manager
22 Jan 2024 //
GLOBENEWSWIRE
Nusano to Host Virtual KOL Event on Emerging Trends in Radiotherapeutics
12 Dec 2023 //
GLOBENEWSWIRE
Nusano to Participate in October Investor Conferences
28 Sep 2023 //
GLOBENEWSWIRE
Nusano Appoints Industry Expert Alexandre Gibim as Chief Operations Officer
15 Sep 2023 //
GLOBENEWSWIRE
Nusano to Participate in Isotope and Radiopharmaceutical Conferences
20 Jul 2023 //
GLOBENEWSWIRE
